BCR and chronic myelogenous leukemia, BCR-ABL1 positive: We tested the ability of SNIPE to kill chronic myeloid leukemia (CML) K562 cells that carry a Philadelphia chromosome, i.e., a reciprocal translocation of chromosome 9 and 22 that results in the fusion oncogene BCR-ABL156,57 (Fig. 5e).